Rowasa and anal fistula Patient Reports February 12, 2012

Rowasa Side Effects Report #5162046-8
Rowasa side effect was reported by a Consumer or non-health professional from FRANCE on Nov 06, 2006. Female patient, 43 years of age, was diagnosed with enterocolitis haemorrhagic, rectal cancer and was treated with Rowasa. After drug was administered, patient experienced the following side effects: anal fistula, anorectal disorder, candidiasis, diarrhoea, intestinal perforation, proctalgia, rectal cancer, sepsis , vaginal disorder. Rowasa dosage: 500 MG QDAY RC. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.